Serina Therapeutics (SER) Live Share Price, Invest From India

Serina Therapeutics Stock Performance

as on September 23, 2026 at 6:59 am IST

Day's Low
Day's High
$2.17
Day's Price Range
$2.43
$2.35
7.66%
Downside
3.40%
Upside
52 Week's Low
52 Week's High
$1.22
52-Week Price Range
$5.83
$2.35
48.09%
Downside
148.09%
Upside

Serina Therapeutics share price movements today

Previous Close: $2.31
Open: $2.25
Volume: 124.7K
Market Cap: $57.2M
Day's Low - High: $2.17 - $2.43
52 Week Low - High: $1.22 - $5.83

Serina Therapeutics Historical Returns

1 Month Return: -19.51 %
3 Month Return: + 22.22 %
1 Year Return: -54.62 %
3 Year Return: 0 %
5 Year Return: 0 %

Serina Therapeutics Stock Fundamentals & Key Indicators

Check Serina Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$57.2M

EPS (TTM)

-1.88

Dividend Yield

0.00%

PE Ratio (TTM)

-1.2

Industry PE ratio

-2.33

PEG Ratio

0.02540596889810745

Return On Equity TTM

-222.42%

Serina Therapeutics Stock Valuation

Track how Serina Therapeutics P/E has moved over time to understand its valuation trends.

Serina Therapeutics in the last 5 years

Overview
Trends

Lowest (-33.16x)

December 31, 2021

Industry (-2.33x)

December 31, 2025

Today (-1.00x)

December 31, 2025

Highest (21.96x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -1.00x

Serina Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Serina Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Serina Therapeutics	Buy	$57.2M	NA	-1.2	0.00%	0.00%
Moderna	Neutral	$61.5B	-60.76%	-19.3	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.8B	177.16%	29.35	86.04%	0.00%
Regeneron	Buy	$80.8B	23.35%	18.48	84.86%	0.47%

Stock Returns calculator for Serina Therapeutics Stock including INR - Dollar returns

The Serina Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Serina Therapeutics investment value today

Current value as on today

₹49,974

Returns

-₹50,026

(-50.03%)

Returns from Serina Therapeutics Stock

-₹53,831 (-53.83%)

Dollar Impact

₹3,805 (+3.8%)

Analyst Recommendation on Serina Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Serina Therapeutics. Average target price of $9.5

Indian Investors' Interest in Serina Therapeutics Stock

Search interest for Serina Therapeutics Stock has increased by 57% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 24, 2026 to September 23, 2026

Change:57% versus previous 30 day period

Serina Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	-	0	0	-	0	-	-	-	-
Gross Profit	0	-	-2	-2	-	0	-3	-3	0	-
Operating Income	-2	-3	-5	-5	-5	-5	-6	-6	-6	-6
EBITDA	-14	5	1	-2	-4	-6	-4	-3	-7	-7
Interest Expense	0	0	0	0	-	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-15	5	1	-2	-4	-6	-4	-3	-6	-6
Income Tax Expense	-	-	-	-	-	-	-	0	0	-
Net Income	-15	5	1	-2	-4	-6	-4	-3	-6	-6
Net Profit Margin	-400.00%	0.00%	100.00%	100.00%	0.00%	87.69%	0.00%	0.00%	0.00%	0.00%

Serina Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Mar 2019	Dec 2019	Mar 2021	Dec 2021	Mar 2023	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	1	1	0	3	0	3	0	-
Gross Profit	0	0	0	-1	0	0	3	0	-
Operating Income	-8	-10	-12	-10	-1	-2	-3	-17	-24
EBITDA	-7	-7	-11	-8	-1	-2	5	-10	-18
Interest Expense	0	-	-	0	0	0	0	0	0
Depreciation	0	0	0	1	0	0	0	0	0
Income Before Tax	-6	-7	-12	-10	-1	-2	5	-11	-19
Income Tax Expense	-	-	0	-	-	-	-	-	0
Net Income	-6	-7	-12	-10	-1	-2	5	-11	-19
Net Profit Margin	51.21%	39.76%	42.22%	-2272.22%	100.00%	100.00%	97.15%	-246.43%	0.00%

Serina Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-9	5	1	-2	-4	-6	-4	-3	-6	-6
Operating Cash Flow	-1	-8	-2	-4	-4	-3	-3	-6	-4	-6
Investing Cash Flow	0	-	0	0	-	0	0	-	0	0
Financing Cash Flow	2	5	0	5	4	5	6	0	26	5
Change in Cash	1	-2	-2	0	0	1	2	-5	21	-1

Serina Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Mar 2019	Dec 2019	Mar 2021	Dec 2021	Mar 2023	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-7	-12	-10	-1	-2	5	-11	-19
Operating Cash Flow	-6	-7	-10	-7	-2	-2	-2	-17	-17
Investing Cash Flow	0	1	0	0	0	0	0	0	0
Financing Cash Flow	13	6	6	5	1	1	10	13	17
Change in Cash	7	0	-4	-1	0	0	7	-3	0

Mutual Funds that own Serina Therapeutics Stock

Check out the Mutual Funds with significant holdings in Serina Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	0.626508%	159136
Fidelity Concord Street Trust	0.142737%	36256
Bridgeway Funds, Inc.	0.009822%	2495

Global Institutional Holdings in Serina Therapeutics

Funds	Holdings
Vanguard	0.7%
Bridgeway	0.01%

Insights on Serina Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -14.0K → 130.0K (in $), with an average increase of 110.8% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -6.89M → -6.35M (in $), with an average increase of 8.5% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 551.1% return, outperforming this stock by 605.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, SER stock has moved down by -19.5%

About Serina Therapeutics

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.

Organisation	Serina Therapeutics
Headquarters	601 Genome Way, Huntsville, AL, 35806, US
Industry	Biotechnology
CEO	Steven A. Ledger
E-voting on shares	Click here to vote

Key Management of Serina Therapeutics

Name	Title
Dr. Balkrishan Gill Ph.D.	Executive Co-Chairman of the Board
Mr. Steven A. Ledger	CEO & Director
Dr. J. Milton Harris Ph.D.	Co-Founder, Director Emeritus & Chair of Scientific Advisory Board
Dr. Srini Tenjarla Ph.D.	Chief Technical Operations Officer
Dr. Randall W. Moreadith M.D., Ph.D.	Chief Development Officer
Mr. Gregory S. Curhan	Chief Financial Officer
Dr. Joshua Thomas Ph.D.	Head of Chemistry

FAQs

What is Serina Therapeutics share price today?

Serina Therapeutics share price today is $2.35 as on September 23, 2026 at 1:29 am IST at the close of the market. Serina Therapeutics share today touched a day high of $2.43 and a low of $2.17.

What is the 52 week high and 52 week low for Serina Therapeutics share?

Serina Therapeutics share touched a 52 week high of $5.83 on October 8, 2025 and a 52 week low of $1.22 on March 18, 2026. Serina Therapeutics stock price today i.e. September 23, 2026 at 1:29 am IST is closed at $2.35,which is 59.69% down from its 52 week high and 92.62% up from its 52 week low.

What is Serina Therapeutics's market capitalisation today?

Serina Therapeutics market capitalisation is $0.00T as on September 23, 2026 at 1:29 am IST.

How to invest in Serina Therapeutics Stock (SER) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Serina Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Serina Therapeutics Shares that will get you 0.6383 shares as per Serina Therapeutics share price of $2.35 per share as on September 23, 2026 at 1:29 am IST.

What is the minimum amount required to buy Serina Therapeutics Stock (SER) from India?

Indian investors can start investing in Serina Therapeutics (SER) shares with as little as ₹95.58 or $1 (as of September 23, 2026 at 4:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.80 in Serina Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 23, 2026 at 4:39 am IST). Based on Serina Therapeutics share’s latest price of $2.35 as on September 23, 2026 at 1:29 am IST, you will get 4.2553 shares of Serina Therapeutics. Learn more about fractional shares .